Clinical Trials Directory

Trials / Completed

CompletedNCT02602912

Identification of Spine Structures by Using BIP-Needles

INJ-SPINE-01 Identification of Spine Structures by Using BIP-Needles

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Injeq Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main purpose of the study is to assess the feasibility and clinical performance of impedance based tissue identification in various spine structures.

Conditions

Interventions

TypeNameDescription
DEVICEInjeq Bioimpedance Probe (BIP) NeedleInjeq Bioimpedance Probe (BIP) Needle is a spinal needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with cerebrospinal fluid.

Timeline

Start date
2015-05-01
Primary completion
2018-11-01
Completion
2018-11-01
First posted
2015-11-11
Last updated
2019-02-27

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02602912. Inclusion in this directory is not an endorsement.

Identification of Spine Structures by Using BIP-Needles (NCT02602912) · Clinical Trials Directory